USPTO serial 75354211
BETOVAC
Reviewed by CopyMark Law Group
Reg. 2386761Status 710
- Filing date
- Status date
- Registration date
- Sep 19, 2000
- Examiner
- DALIER, JOHN DAVID
- Law office
- TMEG LAW OFFICE 104
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with BETOVAC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Oxford, OX4 4GA, GB
Oxford, OX4 4GA, GB
Oxford, OX4 4GA, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DONALD N HUFF
DONALD N HUFF DYKEMA GOSSETT, PLLCSTE 300 W1300 I ST NWWASHINGTON, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations | SECTION 8 - CANCELLED | — |
| 005 | clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing lipsome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy, pharmaceutical preparations for the treatment of cancer | SECTION 8 - CANCELLED | — |
| 010 | instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters, tubes for the administration of gene therapy, except for containers for receiving of a patient's blood | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named BETOVAC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2007 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Feb 15, 2006 | CFIT | CASE FILE IN TICRS | — |
| Jul 7, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 19, 2000 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 27, 2000 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 26, 2000 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 5, 1999 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 4, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 29, 1998 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 24, 1998 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 1998 | DOCK | ASSIGNED TO EXAMINER | — |